Obese Older Women Have An Increased Risk Of Breast Cancer eFluxMedia - Nov 28, 2008 In fact, the researchers said that heavy women have an increased level of estrogen, which appears to fuel tumors leading to ?estrogen receptor-positive? ...
22 federal suits filed over hormone replacement drugs West Virginia Record, WV - Nov 29, 2008 He wrote a book called "Feminine Forever" where he recommended estrogen for menopause, saying that women who used the drugs "will be much more pleasant to ...
Estrogen, Testosterone May Affect Atherosclerosis Johns Hopkins Gazette, MD - Nov 17, 2008 The findings may help explain the increased risk men have of developing heart disease, which runs about twofold higher than women's heart disease risk ...
Thinning Hair in Women: Warning Sign of Underlying Health Issues Natural News.com, AZ - Nov 27, 2008 Although estrogen is the primary hormone of women, they also produce testosterone and other androgens such as DHEA. As the body ages women may begin to ...
Recent News and Articles on the Keywords: disease + heart + 18,200 Related to the article below (Last Update: 8/7/2008)
Business Briefcase Tampa Tribune, FL - Jul 20, 2008 Dixon is a graduate of Washington University in Washington, DC Her topic of discussion will be "Cardiovascular Anatomy and Disease." The Heart Institute at ...
[CITATION] Differences in cardiovascular disease mortality and major risk factors between districts in Oslo. An … - AK Jenum, I Stensvold, DS Thelle - Int J Epidemiol, 2001 - IEA ... a population of between 6700 and 28 400 (median 18200), constituted an ... level of
mortality from cardiovascular disease (CVD), coronary heartdisease (CHD) and ...
Electrical Alternans of the STSegment in Non-PrinzmetaPs Angina - G DEMIDOWICH, R WERRES, D ROTHFELD, J BECKER - Pacing and Clinical Electrophysiology, 1980 - Blackwell Synergy ... later was negative at the maximum pre- dicted heart rate (? 2 ... non-Prinzmetal angina
caused by triple vessel coronary artery disease. ... Cardioi., 18:200, 1966 ...
Abnormal intracellular Ca2+ homeostasis and disease - L Missiaen, W Robberecht, LVD Bosch, G Callewaert, … - Cell Calcium, 2000 - Elsevier ... mice, manic-depressive illness and perhaps Alzheimer?s disease. Various abnormalities
in Ca 2+ -handling proteins have been described in heart during aging ...
Estrogen therapy does not appear to protect postmenopausal women from heart disease
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years.
The study is published in the Archives of Internal Medicine.
The Women's Health Initiative ( WHI ) included two large clinical trials that evaluated whether hormone therapy with estrogen reduces the risk of coronary heart disease in postmenopausal women.
In the part of the study designed to test estrogen therapy alone, 10,739 women aged 50 to 79 years who had undergone hysterectomy were assigned to take either conjugated equine estrogens -- a mix of several estrogens -- or a placebo.
Though researchers had planned to study the women for 8.5 years, the estrogen-only trial was stopped in March 2004 after only 6.8 years because the hormone treatment appeared to increase the risk of stroke.
Judith Hsia, of George Washington University, Washington, D.C., and colleagues analyzed data from the estrogen-only portion of the WHI study.
During the course of the trial, the women taking hormones experienced 201 coronary events, which included heart attacks and coronary deaths, while those taking placebo had 217 events. Overall, the risk was similar for women who took hormones compared with those who did not, though there was a suggestion of lower risk in women age 50 to 59 years.
Among these women ( a total of 1,396 ) who were aged 50 to 59 years at the start of the study, there was no significant reduction in myocardial infarction or coronary death among those taking estrogen.
However, coronary revascularization was less frequent among women taking estrogen, as were several combined endpoints, such as myocardial infarction, coronary death and revascularization.
" This trial may have been unable to demonstrate a significant difference in the risk of myocardial infarction or coronary death by age group because of the low event rate in young women," the authors report.
